Skip to main content
Log in

Comparative study of mifentidine and ranitidine in the short-term treatment of duodenal ulcer

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The efficacy and safety of mifentidine 20 mg at night, a new, potent, long-acting H2-receptor antagonist, has been compared with ranitidine 300 mg at night in 60 patients with acute duodenal ulcer, in a randomized double-blind study. Antacid tablets were allowed as additional treatment for pain relief. The treatment lasted for 4 weeks.

After 4 weeks of treatment the healing rate was similar; amongst the patients who completed the treatment, healing was 68% for mifentidine, 63% for ranitidine, and on intention-to-treat analysis, healing in both groups was 63%. Pain relief and antacid consumption were similar in both groups.

Clinically significant adverse effects were not detected and any changes in laboratory values were minimal, clinically insignificant and reversible.

Mifentidine appears to be an effective and safe once-a-day treatment for acute duodenal ulcer disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Chiverton SG, Hunt RH (1988) Medical regimens in short and long-term ulcer management. Clin Gastroenterol 2: 655–676

    Google Scholar 

  2. Howden CW, Jones DB, Hunt RH (1985) Nocturnal doses of H2-receptor antagonist for duodenal ulcer. Lancet I: 647–648

    Google Scholar 

  3. Imbimbo BP, Urso R, Sturn B, Ueckert B, Vidi A, Ladinsky H, Daniotti S (1988) Pharmacokinetics of mifentidine after single and multiple oral administration to healthy volunteers. Br J Clin Pharmacol 26: 407–413

    Google Scholar 

  4. Imbimbo BP, Seiberling M, Peukert U, Hoexter G, Maier-Lenz H, Vidi A, Daniotti S (1988) Safety and pharmacokinetics of mifentidine after increasing oral doses in healthy subjects. Eur J Clin Pharmacol 35: 673–676

    Google Scholar 

  5. Lazzaroni M, Ardizzone S, Imbimbo BP, Sangaletti O, Ghirardosi C, Bianchi Porro G (1987) Effect of mifentidine, a new H2-antagonist, on pentagastrin stimulated acid secretion in healthy subjects. Int J Clin Pharmacol Ther Toxicol 25: 218–221

    Google Scholar 

  6. Lazzaroni M, Imbimbo BP, Sangaletti O, Bianchi Porro G (1988) Gastric acid and pepsin secretion after single oral dose of mifentidine in healthy subjects. Scand J Gastroenterol 23: 788–792

    Google Scholar 

  7. Bianchi Porro G, Lazzaroni M, Imbimbo BP, Sangaletti O, Ghirardosi C, Daniotti S (1987) Action of mifentidine, a new H2-antagonist, on secretory response to sham feeding and pentagastrin and upon serum gastrin in duodenal ulcer patients. Eur J Clin Pharmacol 32: 555–558

    Google Scholar 

  8. Bianchi Porro G, Imbimbo BP, Lazzaroni M (1988) Effect of mifentidine on peptone meal-stimulated gastric acid secretion and plasma gastrin levels in duodenal ulcer patients. Agents Action 25: 222–226

    Google Scholar 

  9. Ireland A, Gear P, Colin-Jones DG, Golding PL, Ramage JK, Williams JG, Leicester RG, Smith CL, Ross G, Bamforth J, Degara CJ, Gledhill T, Hunt RH (1984) Ranitidine 150 mg twice daily vs 300 mg nightly in treatment of duodenal ulcer. Lancet II: 274–275

    Google Scholar 

  10. Simon B, Bianchi Porro G, Cremer M, Dobrilla G, Haglund U, Dunn SL, Summers K (1986) A single night-time dose of ranitidine 300 mg vs ranitidine 150 mg twice daily in the acute treatment of duodenal ulcer: a European multi-centre trial. J Clin Gastroenterol 8: 367–370

    Google Scholar 

  11. Gledhill T, Howard OM, Buck M, Paul A, Hunt RH (1983) Single nocturnal dose of an H2-receptor antagonist for the treatment of duodenal ulcer. Gut 24: 904–908

    Google Scholar 

  12. Sabbatini F, Piai G, Castiglione F, Petrelli G, Imbimbo BP, Mazzacca G (1988) Single daily doses of mifentidine on inhibition of intragastric acidity: controlled study vs ranitidine and placebo. Gastroenterology 94: A 392

  13. Bianchi Porro G, Petrillo M, Lazzaroni M, Leto di Priolo S (1981) Healing of duodenal ulcer with twice daily oxmetidine. In: Baron JH (ed). Cimetidine in the 80's. Livingstone, Edinburgh, pp 27–33

    Google Scholar 

  14. Lauritsen K, Rune SJ, Wulff HR, Olsen JH, Laursen LS, Havelund T, Astrup L, Bendtsen F, Linde J, Bytzer P, Tage Jensen U, Gluud C, Andersen HH, Schlichting P, Skovbjerg A, Mertz-Nielsen A, Rask-Madsen J (1988) Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double-blind study comparative trial. Gut 29: 249–253

    Google Scholar 

  15. Misiewicz JJ (1978) Peptic ulceration and its correlation with symptoms. Clin Gastroenterol 7: 571–582

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sabbatini, F., Lazzaroni, M., Petrillo, M. et al. Comparative study of mifentidine and ranitidine in the short-term treatment of duodenal ulcer. Eur J Clin Pharmacol 39, 515–517 (1990). https://doi.org/10.1007/BF00280946

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00280946

Key words

Navigation